【摘 要】
:
Many of the worlds problematic pathogens continue to lack effective vaccines against them despite vigorous vaccine development efforts.It appears that many of these "vaccine resistant" pathogens escap
【机 构】
:
Biological Mimetics,Inc.USA
【出 处】
:
中国上海第七届国际新药发明科技年会
论文部分内容阅读
Many of the worlds problematic pathogens continue to lack effective vaccines against them despite vigorous vaccine development efforts.It appears that many of these "vaccine resistant" pathogens escape natural host immune responses by inducing strain-specific immunity to immunodominant epitopes that are subsequently able to mutate altering their antigenic profiles.The immune system appears to be decoyed into reacting to these immunodominant epitopes that offer little cross protection between other serotypes or subtypes circulating in other hosts as well as quasi species within a host.A large number of pathogens appear to exploit this weakness in the host immune system by focusing antigenic attention upon highly variable epitopes not necessarily essential for function while avoiding immune surveillance against more highly conserved and critical regions that define the essence of the pathogen.Because the propensity of the immune system to react against immunodominant strain-specific epitopes appears to be genetically hard-wired,the phenomenon has been termed "deceptive imprinting." Because of the deceptive imprinting phenomenon,traditional vaccine development strategies are hampered in their ability to elicit broadly protective immunity against vaccine resistant pathogens; hence,novel approaches are needed such as those that refocus immune responses towards more conserved and desirable targets.Vaccine development strategies designed to circumvent deceptive imprinting and elicit broadly protective immunity against vaccine resistant pathogens will be presented in the context of developing broadly protective vaccines against human immunodeficiency virus,influenza virus,and human rhinovirus.
其他文献
Toll-like receptors (TLRs) 7,8,and 9 belong to a family of pathogen-associated molecular pattern (PAMP) recognition receptors.These receptors have been shown to be expressed in endosomal membranes of
The application of vaccines to cancer is nowadays an attractive possibility thanks to advances in molecular engineering and a better understanding of tumor immunology.Transgenic animal models have pla
Inhibition ofT-cell activation is the most efficient way to prevent transplant rejection.Among the immunosuppressants currently on the market,only calcineurin inhibitors (CNIs) inhibit specifically T-
Human lung cancer is the leading cause of cancer death worldwide.Bevacizumab,a mAb against vascular endothelial growth factor (VEGF),in combination with chemotherapy showed significant therapeutic eff
Description:This symposium is designed to help biotech company scientists understand strategies for dose selection and justification in early development.Methods used to perform pharmacokinetic and ph
Large number of pharmaceutical applications of Chitosan have been studied and reported during last two decades.However few of observations inspired us to study and explore the clinical applications of
Millions of dollars are spent yearly in experiments aimed at reducing the risks inherent in the prediction of toxicity and efficacy of compounds for human medical use.Nonetheless,the predictability of
Testing for the safety of a potential drug has been and maintains to be one major cornerstone and challenge in drug discovery and development.The emerging "new technologies" such as "omics" have incre
Swine share many anatomic and physiologic characteristics with humans which make them one of the primary translational research models.In particular swine display similar physiology to humans for the
With the economic downturn,the R&D budget for drug development had been under a lot of scrunity.Every player is trying to make the most out of their investment.On the other hand,increased awareness on